• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiol . Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-

tetano

Editor, Senior Moderator
J Cardiol


. 2021 Sep 28;S0914-5087(21)00255-0.
doi: 10.1016/j.jjcc.2021.09.013. Online ahead of print.
Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection


Takafumi Saito[SUP] 1 [/SUP], Tetsuo Yamaguchi[SUP] 2 [/SUP], Shunsuke Kuroda[SUP] 3 [/SUP], Takeshi Kitai[SUP] 4 [/SUP], Taishi Yonetsu[SUP] 5 [/SUP], Shun Kohsaka[SUP] 6 [/SUP], Sho Torii[SUP] 7 [/SUP], Koichi Node[SUP] 8 [/SUP], Shingo Matsumoto[SUP] 9 [/SUP], Yuya Matsue[SUP] 10 [/SUP], Takahide Kodama[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Background: Obesity is reported to be a predictor of adverse clinical events in coronavirus disease 2019 (COVID-19) in Western countries. However, there are limited data reported regarding the prognostic impact of obesity in Asian patients. We investigated the relationship between body mass index (BMI) and in-hospital outcomes in 580 Japanese patients with cardiovascular disease and/or risk factors and who were admitted for COVID-19 infection using data from 49 hospitals in Japan.
Methods: We analyzed data from the Clinical Outcomes of COVID-19 Infection in Hospitalized Patients with Cardiovascular Disease and/or Risk Factors (CLAVIS-COVID) registry. BMI was classified into four groups accordance with the definition of the Japan Society for the Study of Obesity, as follows: underweight, <18.5 kg/m[SUP]2[/SUP]; normal range, 18.5 to <25 kg/m[SUP]2[/SUP]; pre-obese, 25 to 30 kg/m[SUP]2[/SUP]; and obese, ≥30 kg/m[SUP]2[/SUP].
Results: In-hospital death occurred in 15.0% (n=87) of the patients and intubation was performed for 139 (24.0%) patients. In a multivariate analysis, we found a significant association between higher BMI and in-hospital mortality [underweight: hazard ratio (HR) 0.47, 95% confidence interval (CI) 0.23-0.97; p=0.041; pre-obese: HR 1.46, 95%CI 0.84-2.55; p=0.18; and obese: HR 3.28, 95%CI 1.34-8.02; p=0.009 vs. normal range]. In contrast, the association between BMI and the intubation rate was not statistically significant.
Conclusions: Obesity was associated with a stepwise increase in the risk of in-hospital mortality in Japanese patients with COVID-19 infection. The threshold BMI for the increased risk of a worse outcome was 30, which was much lower in comparison to Western countries.

Keywords: Body mass index; Cardiovascular disease; Coronavirus disease 2019 (COVID-19); In-hospital mortality; Obesity.
 
Back
Top Bottom